Page 2 - ஈகர் அல்ட்ரா பாதை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஈகர் அல்ட்ரா பாதை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஈகர் அல்ட்ரா பாதை Today - Breaking & Trending Today

Zangerl, Larcher tough it out on the Eiger

Babsi Zangerl and Jacopo Larcherâs first date was going surprisingly well. It was looking like they were going to spend the night together â albeit rappelling 28 rope lengths down a sheer rock face.
The cable car had shut down hours ago, and the pair were still climbing, off route and hopelessly behind schedule, hundreds of feet off the deck on the south face of Marmolada, the highest peak in northeast Italyâs Dolomites.
âMy German was really bad at that time,â said Larcher, who is Italian, âand we couldnât really communicate because we were both tired.â
The plan had been to top out the route at 2 p.m. and take a leisurely ride back down the mountain to Malga Ciapela among the sightseers and tourists. Instead, the sun was sinking below the horizon and they were lost in a sea of dolostone. To make matters worse, they had only one headlamp between them. ....

United States , Italy General , El Capitan , Dean Potter , Jacopo Larcher , Robert Jasper , Malga Ciapela , Babsi Zangerl , Thomas Huber , Teton Climber Coalition , National Geographic Adventurer Of The Year , South Face , National Geographic Adventurer , Roger Sch , Japanese Direttissima , American Alpine , Yosemite Decimal System , Magic Mushroom , Deep Blue Sea , Eiger North Face , Eternal Flame , Trango Tower , Teton Climbers Coalition , Babsi Larcher , Super Human , Free Climbing ,

Eiger BioPharmaceuticals : Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Global Phase 3 D-LIVR study enrollment completion planned in 2021
Peginterferon Lambda for HDV
Global Phase 3 LIMT-2 study initiation planned in 2021
Zokinvy™ (lonafarnib) for Progeria and Processing-Deficient Progeroid Laminopathies
U.S. commercial launch in January 2021
EMA decision expected in 2H21
Lambda for COVID-19
Lancet Respiratory Medicine (Feld et al, 2021)
Considering strategic options to advance program
Avexitide for Post-Bariatric Hypoglycemia (PBH)
Positive Phase 2 PREVENT study published in
JCEM (Craig et al, 2021)
Corporate
Pro-forma cash, cash equivalents and investments of $176.2M, including $128.8M as of December 31, 2020 plus $47.4M from net PRV sale proceeds received in January 2021, expected to fund planned operations through Q4 2023
Fourth Quarter and Full Year 2020 Financial Results ....

Progeroid Laminopathies , David Cory , Drug Administration , Program Product Updates , Company Annual Report On Form , Prnewswire Eiger Biopharmaceuticals Inc , European Medicines Agency , Eiger Biopharmaceuticals Inc , Access Program , Hepatitis Delta Virus , Processing Deficient Progeroid , Lancet Respiratory Medicine , Post Bariatric Hypoglycemia , Full Year , Priority Review Voucher , Hutchinson Gilford Progeria Syndrome , Marketing Authorization Application , Managed Access Program , Quarterly Report , Annual Report , Consolidated Statements , Operations Financial , Eiger Biopharmaceuticals , Inc Stock Exchange , Press Release , Of Eigr ,